Author/Authors :
Sundaravel, Swethika Internal Medicine - University of Miami - Palm Beach Regional Consortium, Atlantis, FL, USA , Alrifai, Abdulah University of Miami - Palm Beach Regional Consortium, Atlantis, FL, USA , Kabach, Mohamad University of Miami - Palm Beach Regional Consortium, Atlantis, FL, USA , Ghumman, Waqas University of Miami - Palm Beach Regional Consortium, Atlantis, FL, USA
Abstract :
Chemotherapy induced cardiotoxicity is becoming increasingly prevalent with several new agents being used recently. The
incidence of Takotsubo cardiomyopathy due to 5-fluorouracil based chemotherapeutic regimens like FOLFOX is not uncommon.
It is also seen with platinum based chemotherapy. Most of these patients have reversible cardiotoxicity and the cardiac function
recovers within a short period with supportive treatment. Here we have a patient who presented with cardiogenic shock after 5 days
of receiving FOLFOX regimen for colorectal adenocarcinoma. She was treated with a percutaneous left ventricular assist device,
Impella CP, for hemodynamic support with excellent outcome.
